Clinical Trial Update: A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients [Phase 3]

View source ↗

Summary

Phase III trial comparing remimazolam to placebo and midazolam in colonoscopy patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colonoscopy-related Procedural Sedation

Drugs mentioned

• Midazolam (Midazolam)
• Remimazolam (remimazolam)

Snippet

Sponsor: Paion UK Ltd. | Conditions: Colonoscopy | Phase 3 | Status: COMPLETED | Results posted: 2018-11-09